Solenis wraps up acquisition of Diversey for $4.6bn
Diversey is a provider of hygiene, infection prevention and cleaning products and technology and will help develop cross-selling…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
06 Jul 23
Diversey is a provider of hygiene, infection prevention and cleaning products and technology and will help develop cross-selling…
06 Jul 23
Under the contract, Evotec Biologics will develop drug product prototype(s) from discovery through the execution of Phase 1…
06 Jul 23
Sapio's platform offers a comprehensive solution by integrating various lab informatics components, including a laboratory information management system…
06 Jul 23
The FDA is concerned that these products can be accidentally ingested by consumers, including children, or taken in…
06 Jul 23
Brii Biosciences has acquired worldwide exclusive license to VBI-2601 and an exclusive license for PreHevbri in the Asia…
05 Jul 23
The EC authorisation is supported by positive data from the Phase ½ FOENIX-CCA2 clinical trial, in which Lytgobi…
05 Jul 23
The patent is said to validate the unique combination of multiepitope that is given to patients with HLA-A2…
05 Jul 23
In the trial, most patients who received JNJ-2113 achieved the primary endpoint of Psoriasis Area and Severity Index…
05 Jul 23
Under the agreements, Samsung Biologics will manufacture biosimilar products ranging from oncology and inflammation to immunotherapy in the…
05 Jul 23
The pivotal clinical trial approved in China will evaluate the efficacy and safety of Glecirasib as a single…